Early infection detection in preterm babies
Part of Infections clinical trials.
This study looks at early signs of infection in premature babies. It checks two substances in the baby's blood (IL-6 and PCT) within the first 12 hours after birth to see if they can help detect sepsis early. Participation involves collecting a small extra blood sample during routine tests.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Baby is born before 37 weeks of pregnancy (preterm).
- Baby is admitted to the neonatal intensive care unit (NICU) at the Medical University of Graz after birth.
- Written informed consent from parents or guardians is provided before the study begins.
- Baby requires a blood gas analysis within the first 12 hours after birth (as part of routine care).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new biomarker (T6A) to detect bacterial infections in newborn babies. It aims to help doctors diagnose infections faster and more accurately.
This study looks at how blood markers like lactate and complete blood count (CBC) can help spot infection in newborns up to 28 days old. It may lead to faster, more accurate diagnosis for babies with possible sepsis.
This study looks at a specific blood protein level in children from birth to age 17. It compares healthy children and those with sepsis to see if the protein changes during infection.
This trial is testing whether a new, highly sensitive blood test (droplet digital PCR) combined with genetic analysis can help doctors predict sepsis earlier in emergency room patients. This could lead to faster treatment and better outcomes.
This trial is looking for patients who have an infection and are showing early signs of getting sicker, like a high warning score. It aims to find out if doctors can identify those at risk of sepsis sooner so they can start treatment earlier.
This trial checks if a new tool can help doctors spot sepsis early in children. If your child is under 18, had a blood culture, and received strong antibiotics within the first day in the hospital, they may qualify.
Hear when a new Neonate trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.